Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan A Wilson

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Bioorganic & Medicinal Chemistry|June 22, 2012
Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptorsMatthew D Moran, Alan A Wilson, Charles S Elmore, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PETSharon Ashworth, Eugenii A Rabiner, Roger N Gunn, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 2019
Replicating predictive serum correlates of greater translocator protein distribution volume in brainSophia Attwells, Elaine Setiawan, Alan A Wilson, et al.
Nuclear Medicine and Biology|July 19, 2017
Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous systemAlan A Wilson, Oleg Sadovski, José N Nobrega, et al.
Archives of General Psychiatry|June 5, 2002
Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635Johannes Tauscher, Shitij Kapur, N Paul L G Verhoeff, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 15, 2007
A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer diseaseKrista L Lanctôt, Doug F Hussey, Nathan Herrmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2015
[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disordersDoris E Payer, Mark Guttman, Stephen J Kish, et al.
Plos One|September 19, 2015
Imaging Striatal Microglial Activation in Patients with Parkinson's DiseaseYuko Koshimori, Ji-Hyun Ko, Romina Mizrahi, et al.
International Journal of Geriatric Psychiatry|June 8, 2012
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot studyTiffany W Chow, David Fam, Ariel Graff-Guerrero, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry|June 22, 2012
Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptorsMatthew D Moran, Alan A Wilson, Charles S Elmore, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PETSharon Ashworth, Eugenii A Rabiner, Roger N Gunn, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 2019
Replicating predictive serum correlates of greater translocator protein distribution volume in brainSophia Attwells, Elaine Setiawan, Alan A Wilson, et al.
Nuclear Medicine and Biology|July 19, 2017
Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous systemAlan A Wilson, Oleg Sadovski, José N Nobrega, et al.
Archives of General Psychiatry|June 5, 2002
Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635Johannes Tauscher, Shitij Kapur, N Paul L G Verhoeff, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 15, 2007
A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer diseaseKrista L Lanctôt, Doug F Hussey, Nathan Herrmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2015
[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disordersDoris E Payer, Mark Guttman, Stephen J Kish, et al.
Plos One|September 19, 2015
Imaging Striatal Microglial Activation in Patients with Parkinson's DiseaseYuko Koshimori, Ji-Hyun Ko, Romina Mizrahi, et al.
International Journal of Geriatric Psychiatry|June 8, 2012
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot studyTiffany W Chow, David Fam, Ariel Graff-Guerrero, et al.
Pageof 18